U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H33FO6
Molecular Weight 436.5136
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLURANDRENOLIDE

SMILES

CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

InChI

InChIKey=POPFMWWJOGLOIF-XWCQMRHXSA-N
InChI=1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H33FO6
Molecular Weight 436.5136
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Flurandrenolide is a potent corticosteroid intended for topical use. Flurandrenolide occurs as white to off-white, fluffy, crystalline powder and is odorless. Flurandrenolide is practically insoluble in water and in the ether. Cordran is primarily effective because of its anti-inflammatory, antipruritic, and vasoconstrictive actions. The mechanism of the anti-inflammatory effect of topical corticosteroids is not completely understood. Corticosteroids with anti-inflammatory activity may stabilize cellular and lysosomal membranes. There is also the suggestion that the effect on the membranes of lysosomes prevents the release of proteolytic enzymes and, thus, plays a part in reducing inflammation. Flurandrenolide is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
8.74 null [pKd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CORDRAN SP

Approved Use

Cordran® (flurandrenolide, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Launch Date

1965
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
1976 Aug
Extensive keloid formation and progression after each vaccination.
2007 Jul-Aug
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011 Jul 14
A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discovery.
2012 Aug
Patents

Sample Use Guides

For moist lesions, a small quantity of the cream should be rubbed gently into the affected areas 2 or 3 times a day. For dry, scaly lesions, the ointment is applied as a thin film to affected areas 2 or 3 times daily. Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Route of Administration: Topical
In Vitro Use Guide
Cultured rat hepatoma (HTC) cells were grown in the absence of added steroid. Cytosol was incubated with [3H]dexamethasone (3 nM final concentration) with or without competing Flurandrenolide (14-18 h at 00C) and specific binding was measured by the charcoal assay.
Substance Class Chemical
Created
by admin
on Wed Apr 02 07:33:19 GMT 2025
Edited
by admin
on Wed Apr 02 07:33:19 GMT 2025
Record UNII
8EUL29XUQT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLURANDRENOLIDE
HSDB   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF  
USAN  
Official Name English
FLUDROXYCORTIDE
INN   JAN   MART.   WHO-DD  
INN  
Preferred Name English
Fludroxycortide [WHO-DD]
Common Name English
6?-Fluoro-11?,16?,17,21-tetrahydroxypregn-4-ene-3,20-dione, cyclic 16,17-acetal with acetone
Common Name English
FLURANDRENOLIDE [USAN]
Common Name English
FLURANDRENOLIDE [ORANGE BOOK]
Common Name English
33379
Code English
NSC-757869
Code English
FLURANDRENOLIDE [USP MONOGRAPH]
Common Name English
FLUDROXYCORTIDE [MART.]
Common Name English
FLURANDRENOLIDE [HSDB]
Common Name English
CORDRAN
Brand Name English
FLURANDRENOLIDE [MI]
Common Name English
PREGN-4-ENE-3,20-DIONE, 6-FLUORO-11,21-DIHYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-, (6.ALPHA.,11.BETA.,16.ALPHA.)-
Common Name English
FLURANDRENOLONE
Common Name English
FLUDROXYCORTIDE [JAN]
Common Name English
FLURANDRENOLIDE [USP-RS]
Common Name English
fludroxycortide [INN]
Common Name English
CORDRAN-N COMPONENT FLURANDRENOLIDE
Common Name English
FLURANDRENOLIDE [VANDF]
Common Name English
Classification Tree Code System Code
WHO-VATC QD07AC07
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
WHO-ATC D07CC03
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
WHO-VATC QD07CC03
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
WHO-ATC D07AC07
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
NDF-RT N0000175450
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
NDF-RT N0000175576
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
NCI_THESAURUS C521
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1201012
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
MESH
D005478
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
CAS
1524-88-5
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
INN
1123
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
216-196-8
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
MERCK INDEX
m5497
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY Merck Index
HSDB
3084
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
FDA UNII
8EUL29XUQT
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
RXCUI
4500
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY RxNorm
NSC
757869
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
SMS_ID
100000092412
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
DRUG CENTRAL
1217
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
PUBCHEM
15209
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
WIKIPEDIA
FLUDROXYCORTIDE
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
IUPHAR
7606
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
DRUG BANK
DB00846
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
EVMPD
SUB07685MIG
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID2047434
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
DAILYMED
8EUL29XUQT
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
LACTMED
Flurandrenolide
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
NCI_THESAURUS
C47537
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
RS_ITEM_NUM
1284000
Created by admin on Wed Apr 02 07:33:19 GMT 2025 , Edited by admin on Wed Apr 02 07:33:19 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY